Basic information Safety Supplier Related

1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-

Basic information Safety Supplier Related

1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- Basic information

Product Name:
1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-
Synonyms:
  • 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-
  • Neuromuscular Disorder-Targeting Compound 1
CAS:
374538-23-5
MF:
C15H25N3S
MW:
279.44
Mol File:
374538-23-5.mol
More
Less

1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- Chemical Properties

Boiling point:
452.3±40.0 °C(Predicted)
Density 
1.089±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
pka
15.32±0.40(Predicted)
More
Less

1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- Usage And Synthesis

Uses

Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.

References

[1] Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1.

1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-Supplier

MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 15801484223;
Email
psaitong@jm-bio.com
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn